Loblaw-Shoppers Drug deal gets support from proxy firms
(Reuters) - Two independent proxy advisory firms have recommended that Shoppers Drug Mart (SC.TO) shareholders vote in favor of Loblaw Co Ltd's (L.TO) C$12.4 billion ($11.76 billion) takeover offer, the Canadian pharmacy chain said on Tuesday.
Institutional Shareholder Services Inc (ISS) and Glass Lewis & Co, which offer advice on shareholder votes, both backed the deal. Glass Lewis noted the deal offers attractive diversification at a time of increasing competition in Canada.
Shoppers is Canada's biggest drugstore chain, and Loblaw is the country's biggest grocery chain.
Shareholders of Shoppers are expected to approve the acquisition, Canada's biggest deal so far this year, when they vote at a special meeting on September 12, Shoppers CEO Domenic Pilla told Reuters last week.
NEW YORK - U.S. stocks fell on Thursday, with the Dow and S&P 500 dropping for a fifth straight session after a round of mixed economic data left traders guessing as to when the Federal Reserve would begin to slow its stimulus program.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.